Desarrollo de estrategias terapéuticas y de diagnostico.
NANOCHEMBIO
![Foto de Desarrollo de estrategias terapéuticas y de diagnostico.](/img/grupo.png)
![Foto de University of Oxford](/img/noimage_org.png)
University of Oxford
Oxford, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Oxford (2)
2023
-
N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect
European Journal of Medicinal Chemistry, Vol. 258
2022
-
Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles
Pharmaceutics, Vol. 14, Núm. 4